Anti-EpCAM monoclonal antibody (MAb17-1A) based treatment combined with alpha-interferon, 5-fluorouracil and granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
2004 (English)In: Int J Oncol, ISSN 1019-6439, Vol. 25, no 3, 703-11 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2004. Vol. 25, no 3, 703-11 p.
Adult, Aged, Antibodies; Monoclonal/administration & dosage/adverse effects/*therapeutic use, Antigens; Neoplasm/immunology, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Carcinoma/*drug therapy/mortality/secondary, Cell Adhesion Molecules/antagonists & inhibitors/immunology, Colorectal Neoplasms/*drug therapy/mortality/pathology, Female, Fluorouracil/administration & dosage/adverse effects, Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage/adverse effects, Humans, Interferon-alpha/administration & dosage/adverse effects, Male, Middle Aged, Research Support; Non-U.S. Gov't
Cancer and Oncology
IdentifiersURN: urn:nbn:se:uu:diva-70094PubMedID: 15289873OAI: oai:DiVA.org:uu-70094DiVA: diva2:98005